CannaMD
NOVEMBER 20, 2020
a wealth of new research legitimizing marijuana’s role in patient care – here we are. Between 2000-2018, United States funding sources invested roughly 20 times more money into exposing marijuana’s harms than exploring its benefits. The Mississippi Monopoly.
Cannabis Law Report
MARCH 3, 2022
Yet in an exit interview published by Rolling Stone in 2000, Clinton appeared to endorse cannabis reform, saying that he thinks that “most small amounts of marijuana have been decriminalized in some places, and should be.”. He also rejected requests to lift a federal ban on harm reduction policies like syringe exchange programs.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
PrestoDoctor
JULY 16, 2019
The DPF changed its name in 2000 when it merged with the Ethan Nadelmann’s Lindesmith Center. In their most recent federal lawsuit, CCA attorneys are representing 5 different plaintiffs, all of whom demonstrate that maintaining cannabis as a schedule 1 drug is unconstitutional and a risk to their health as patients.
PrestoDoctor
JULY 16, 2019
The DPF changed its name in 2000 when it merged with the Ethan Nadelmann’s Lindesmith Center. In their most recent federal lawsuit, CCA attorneys are representing 5 different plaintiffs, all of whom demonstrate that maintaining cannabis as a schedule 1 drug is unconstitutional and a risk to their health as patients.
Cannabis Law Report
SEPTEMBER 12, 2021
Nevada voters approved medical marijuana for people by ballot initiative in 2000. I certainly hope that other states follow Nevada’s lead and provide reassurances to licensed veterinarians that they can administer CBD or talk about it with patients without fear of facing disciplinary proceedings,” he said. A simple question.
CannaMD
NOVEMBER 15, 2020
His findings are sure to alarm medical cannabis professionals and patients alike. research funders, the National Institute on Drug Abuse (NIDA) , spent over $1 billion between 2000 and 2008, with a heavily slanted focus on cannabis abuse and misuse, as well as the negative effects of cannabis. Funding of Marijuana Research.
Cannabis Law Report
APRIL 8, 2022
Later that year, Doblin sued the DEA for the first time. submitted his first DEA application to manufacture marijuana for use in medical research. On May 3, 2021, our study of MDMA-assisted therapy for PTSD achieved successful results for patients with severe, chronic PTSD. Rick Doblin, Ph.D., and Michael Mithoefer, M.D.,
Expert insights. Personalized for you.
80 
Let's personalize your content